Anticancer of genus Syzygium: a systematic review

Aim: One in eight fatalities globally are considered cancer-related. The need for cancer therapy is growing. Natural products continue to play a role in drug development, as up to 50% of authorized drugs in the last 30 years have been isolated from natural sources. Methods: Anticancer, antioxidant,...

Full description

Bibliographic Details
Main Authors: Mahmoud Dogara Abdulrahman, Harmand A. Hama
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2023-04-01
Series:Exploration of Targeted Anti-tumor Therapy
Subjects:
Online Access:https://www.explorationpub.com/Journals/etat/Article/1002134
_version_ 1827954121833971712
author Mahmoud Dogara Abdulrahman
Harmand A. Hama
author_facet Mahmoud Dogara Abdulrahman
Harmand A. Hama
author_sort Mahmoud Dogara Abdulrahman
collection DOAJ
description Aim: One in eight fatalities globally are considered cancer-related. The need for cancer therapy is growing. Natural products continue to play a role in drug development, as up to 50% of authorized drugs in the last 30 years have been isolated from natural sources. Methods: Anticancer, antioxidant, antibacterial, antifungal, antiviral, analgesic, anti-inflammatory, and other actions have all been reported in research papers using plants from the Syzygium genus in the treatment and prevention of disease. Results: Results from the anticancer test showed that the genus, especially Syzygium aqueum, Syzygium samarangense, and Syzygium cumini had significant promise as an anticancer agent in vitro against several cancer cell lines. Numerous factors, including phytochemical composition, increased apoptotic activity, decreased cell proliferation, stopped angiogenesis, and reduced inflammation. Conclusions: These results, despite preliminary, show promise for further purification and investigation of bioactive compounds and extracts within the genus Syzygium for their anticancer properties.
first_indexed 2024-04-09T14:24:07Z
format Article
id doaj.art-a2d9fd6d9ed048cf9369a4ba7d9d4e26
institution Directory Open Access Journal
issn 2692-3114
language English
last_indexed 2024-04-09T14:24:07Z
publishDate 2023-04-01
publisher Open Exploration Publishing Inc.
record_format Article
series Exploration of Targeted Anti-tumor Therapy
spelling doaj.art-a2d9fd6d9ed048cf9369a4ba7d9d4e262023-05-04T09:40:32ZengOpen Exploration Publishing Inc.Exploration of Targeted Anti-tumor Therapy2692-31142023-04-014227329310.37349/etat.2023.00134Anticancer of genus Syzygium: a systematic reviewMahmoud Dogara Abdulrahman0https://orcid.org/0000-0003-0944-7282Harmand A. Hama1https://orcid.org/0000-0003-1307-4271Biology Education Department, Faculty of Education, Tishk International University, Kurdistan Region, Erbil 44001, IraqBiology Education Department, Faculty of Education, Tishk International University, Kurdistan Region, Erbil 44001, IraqAim: One in eight fatalities globally are considered cancer-related. The need for cancer therapy is growing. Natural products continue to play a role in drug development, as up to 50% of authorized drugs in the last 30 years have been isolated from natural sources. Methods: Anticancer, antioxidant, antibacterial, antifungal, antiviral, analgesic, anti-inflammatory, and other actions have all been reported in research papers using plants from the Syzygium genus in the treatment and prevention of disease. Results: Results from the anticancer test showed that the genus, especially Syzygium aqueum, Syzygium samarangense, and Syzygium cumini had significant promise as an anticancer agent in vitro against several cancer cell lines. Numerous factors, including phytochemical composition, increased apoptotic activity, decreased cell proliferation, stopped angiogenesis, and reduced inflammation. Conclusions: These results, despite preliminary, show promise for further purification and investigation of bioactive compounds and extracts within the genus Syzygium for their anticancer properties. https://www.explorationpub.com/Journals/etat/Article/1002134anticanceractivitycancerplants
spellingShingle Mahmoud Dogara Abdulrahman
Harmand A. Hama
Anticancer of genus Syzygium: a systematic review
Exploration of Targeted Anti-tumor Therapy
anticancer
activity
cancer
plants
title Anticancer of genus Syzygium: a systematic review
title_full Anticancer of genus Syzygium: a systematic review
title_fullStr Anticancer of genus Syzygium: a systematic review
title_full_unstemmed Anticancer of genus Syzygium: a systematic review
title_short Anticancer of genus Syzygium: a systematic review
title_sort anticancer of genus syzygium a systematic review
topic anticancer
activity
cancer
plants
url https://www.explorationpub.com/Journals/etat/Article/1002134
work_keys_str_mv AT mahmouddogaraabdulrahman anticancerofgenussyzygiumasystematicreview
AT harmandahama anticancerofgenussyzygiumasystematicreview